Xvivo Perfusion AB (0RKL) Ratios
Xvivo Perfusion AB Ratios
GB:0RKL's free cash flow for Q3 2026 was $0.00. For the 2026 fiscal year, GB:0RKL's free cash flow was decreased by $-53.01M and operating cash flow was $53.01M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.77 | 4.58 | 6.14 | 3.47 | 5.24 |
| Quick Ratio | 3.68 | 3.30 | 5.09 | 2.68 | 4.50 |
| Cash Ratio | 2.45 | 2.34 | 4.06 | 1.83 | 3.81 |
| Solvency Ratio | 0.37 | 0.97 | 0.49 | 0.11 | 0.16 |
| Operating Cash Flow Ratio | 0.85 | 0.63 | 0.34 | 0.21 | -0.12 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -1.24 |
| Net Current Asset Value | $ 427.56M | $ 567.11M | $ 575.84M | $ 164.56M | $ 290.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.01 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.06 | 0.02 | 0.02 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.06 | 0.02 | 0.02 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.12 | 1.11 | 1.13 | 1.21 | 1.20 |
| Debt Service Coverage Ratio | 3.15 | 43.78 | 27.18 | 32.29 | 4.08 |
| Interest Coverage Ratio | 2.10 | 15.77 | 3.52 | 21.19 | 25.30 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.37 | 1.26 | 1.09 | 0.38 | 0.21 |
| Net Debt to EBITDA | -1.09 | -1.40 | -14.67 | -6.03 | -10.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.69% | 74.95% | 74.49% | 71.51% | 72.87% |
| EBIT Margin | 10.21% | 24.99% | 0.70% | 5.64% | 2.69% |
| EBITDA Margin | 18.86% | 33.19% | 5.87% | 9.44% | 15.17% |
| Operating Profit Margin | 11.45% | 10.74% | 0.70% | 5.58% | 2.70% |
| Pretax Profit Margin | 4.75% | 24.31% | 15.82% | 5.37% | 2.58% |
| Net Profit Margin | 3.10% | 20.94% | 15.37% | 4.44% | 3.15% |
| Continuous Operations Profit Margin | 3.10% | 20.94% | 15.37% | 4.44% | 3.15% |
| Net Income Per EBT | 65.26% | 86.11% | 97.14% | 82.58% | 122.31% |
| EBT Per EBIT | 41.46% | 226.31% | 2257.49% | 96.26% | 95.46% |
| Return on Assets (ROA) | 1.06% | 7.17% | 4.18% | 1.06% | 0.53% |
| Return on Equity (ROE) | 1.19% | 7.98% | 4.72% | 1.29% | 0.63% |
| Return on Capital Employed (ROCE) | 4.13% | 3.97% | 0.20% | 1.45% | 0.49% |
| Return on Invested Capital (ROIC) | 2.68% | 3.40% | 0.20% | 1.19% | 0.48% |
| Return on Tangible Assets | 2.72% | 17.30% | 9.42% | 3.32% | 1.32% |
| Earnings Yield | 0.43% | 1.12% | 0.93% | 0.34% | 0.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.50 | 6.22 | 6.09 | 4.16 | 4.33 |
| Payables Turnover | 8.85 | 5.22 | 4.23 | 3.08 | 3.27 |
| Inventory Turnover | 1.12 | 0.91 | 1.08 | 1.11 | 0.90 |
| Fixed Asset Turnover | 3.80 | 5.52 | 6.13 | 8.73 | 9.83 |
| Asset Turnover | 0.34 | 0.34 | 0.27 | 0.24 | 0.17 |
| Working Capital Turnover Ratio | 1.35 | 1.24 | 1.17 | 1.07 | 0.62 |
| Cash Conversion Cycle | 350.53 | 391.66 | 312.68 | 297.77 | 376.54 |
| Days of Sales Outstanding | 66.36 | 58.64 | 59.94 | 87.73 | 84.23 |
| Days of Inventory Outstanding | 325.43 | 402.93 | 339.07 | 328.70 | 403.96 |
| Days of Payables Outstanding | 41.26 | 69.90 | 86.33 | 118.66 | 111.65 |
| Operating Cycle | 391.79 | 461.56 | 399.01 | 416.43 | 488.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.21 | 3.53 | 1.55 | 0.94 | -0.42 |
| Free Cash Flow Per Share | -4.82 | -2.60 | -3.26 | -3.49 | -3.68 |
| Dividend Paid and CapEx Coverage Ratio | 1.00 | 0.58 | 1.08 | 0.21 | -0.13 |
| Capital Expenditure Coverage Ratio | 1.00 | 0.58 | 1.08 | 0.21 | -0.13 |
| Operating Cash Flow Coverage Ratio | 0.81 | 3.27 | 1.47 | 2.78 | -2.11 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.14 | 0.08 | 0.07 | -0.05 |
| Free Cash Flow Yield | -2.58% | -0.53% | -0.99% | -1.91% | -1.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 233.25 | 89.40 | 107.42 | 293.22 | 985.47 |
| Price-to-Sales (P/S) Ratio | 7.24 | 18.73 | 16.51 | 13.01 | 31.09 |
| Price-to-Book (P/B) Ratio | 2.78 | 7.14 | 5.07 | 3.78 | 6.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -38.71 | -188.16 | -101.01 | -52.41 | -75.69 |
| Price-to-Operating Cash Flow Ratio | 58.16 | 138.41 | 213.10 | 193.97 | -666.19 |
| Price-to-Earnings Growth (PEG) Ratio | -2.73 | 1.14 | 0.27 | 2.41 | -8.39 |
| Enterprise Value Multiple | 37.29 | 55.03 | 266.74 | 131.77 | 194.92 |
| Enterprise Value | 5.71B | 15.02B | 9.35B | 5.17B | 7.64B |
| EV to EBITDA | 37.29 | 55.03 | 266.74 | 131.77 | 194.92 |
| EV to Sales | 7.03 | 18.27 | 15.65 | 12.44 | 29.57 |
| EV to Free Cash Flow | -37.61 | -183.50 | -95.74 | -50.12 | -71.99 |
| EV to Operating Cash Flow | 56.50 | 134.98 | 201.99 | 185.48 | -633.60 |
| Tangible Book Value Per Share | 21.05 | 23.79 | 24.21 | 8.53 | 12.48 |
| Shareholders’ Equity Per Share | 67.10 | 68.47 | 64.98 | 48.44 | 44.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.35 | 0.14 | 0.03 | 0.17 | -0.22 |
| Revenue Per Share | 25.78 | 26.11 | 19.96 | 14.07 | 8.96 |
| Net Income Per Share | 0.80 | 5.47 | 3.07 | 0.62 | 0.28 |
| Tax Burden | 0.65 | 0.86 | 0.97 | 0.83 | 1.22 |
| Interest Burden | 0.46 | 0.97 | 22.57 | 0.95 | 0.96 |
| Research & Development to Revenue | 0.12 | 0.18 | 0.23 | 0.17 | 0.21 |
| SG&A to Revenue | 0.46 | 0.46 | 0.13 | 0.17 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 4.02 | 0.56 | 0.50 | 1.25 | -1.81 |
Currency in SEK
